AGTC – Genetic Therapy For Rare Diseases
Sue Washer, President and CEO of AGTC, a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthal...
Sue Washer, President and CEO of AGTC, a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthal...
A recent study shows that although eating disorders are traditionally considered to affect mainly women, men represent a growing proportion of individua...
Jeffrey Gelblum, MD, board member at First Choice Neurology and expert consultant to the State of Florida discusses the future of virtual and digital me...
Returning guest, James Sapirstein, President and CEO of First Wave BioPharma (formerly AzurRX), a developer of targeted therapies for gastrointestinal (...
Lisa Meltzer, a sleep psychologist at National Jewish Health discusses the issue of sleep debt. Learn more on Health Professional Radio.
Amy Krambeck, MD, a urologist at Northwestern Memorial Hospital and professor of urology at Northwestern University Feinberg School of Medicine discusse...
Stacey Crew, certified health coach and organizing expert discusses her new book, "Mind, Body, Kitchen: Transform You and Your Kitchen For A Healthier L...
Bill Hinshaw, President and CEO of Axcella Therapeutics, discusses the initiation of a pioneering Phase 2a clinical trial in long COVID, investigating A...
Ezra is a New York-based healthcare technology company utilizing artificial intelligence in medical imaging to provide individuals with a next-generatio...
George Koob, Ph.D., Director of the National Institute on Alcohol Abuse and Alcoholism (NIAAA) at the National Institute of Health (NIH) discusses Dry J...